BioSpace News Archive

Our respiratory system is lined with a thin fluid layer called mucus on the inside.

Organicell Regenerative Medicine, Inc . today reported the results of its Phase 1/2A research program for its biologic therapeutic, Zofin TM , which contains high concentrations of nanoparticles, including exosomes, growth factors, and bio-active proteins.

Yield10 Bioscience, Inc. today announced that the Company recently filed a request for a Regulatory Status Review (RSR) with USDA-APHIS Biotechnology Regulatory Services (BRS) under the SECURE Rule for proprietary elite Camelina varieties containing genes enabling the plant to produce the eicosapentaenoic acid (“EPA”) component of omega-3 oil.

Evolus, Inc. today announced that members of its management team will be participating in Canaccord Genuity’s 43rd Annual Growth Conference in Boston.

Lumos Pharma, Inc. announced it will report its second quarter 2023 financial results after market close on Wednesday, August 9, 2023.

G1 Therapeutics, Inc. will host a webcast and conference call to provide a financial and corporate update for the second quarter 2023 on Wednesday August 2, 2023, at 8:30 a.m. ET.

Anuncia Medical Inc. (“Anuncia” or the “Company”), a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce the successful U.S. commercial launch of the ReFlow™ Mini Flusher device.

Centinel Spine®, LLC, (“the Company”) a leading global medical device company addressing cervical and lumbar spinal disease by providing the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced significant expansion of coverage for lumbar TDR procedures in Michigan.

Noctrix Health, Inc. announced a double feature in the renowned peer-reviewed journal, Sleep, showcasing the outcomes of two major clinical trials that assessed TOMAC therapy for the treatment of RLS.

Edesa Biotech, Inc. announced today that the company will participate in a Fireside Chat and host one-on-one meetings at the Canaccord Genuity 43rd Annual Growth Conference being held in Boston from August 7-10, 2023.